Transplant International · 1994 · 14 citations · 27 references
Life SciencesImmunologySurgeryHepatologyTransplant ImmunologyTransplant SurgeryAllograft RejectionAntibody-mediated RejectionChronic RejectionGraft RejectionLiver TransplantationTransplant RejectionAntibody-mediated Rejection TherapyBiomarkers Of Chronic RejectionLiver Transplant RejectionRejection PathophysiologyTreatment Of Rejection Episodes
We examined 27 hepatectomy specimens to assess the frequency of foam cell endovasculitis and bile duct loss in chronic rejection. Arterial lesions, defined as total occlusion by subintimal foam cells and/or fibromuscular proliferation, were found mainly in hilar and septal arteries, whereas bile duct loss, defined as the absence of bile ducts in more than 50% of portal tracts, affected mainly small tracts. Both were found in 20 livers (74%). In two livers (7%) there was significant bile duct loss but no arterial lesions, whilst in five cases (19%) there were occlusive arterial lesions but no bile duct loss. Small arteries were involved in only 10% of the cases. These results indicate that in one-third of the cases arterial and bile duct lesions develop independently of each other, suggesting different pathogenetic pathways. In addition, liver biopsy may not be pathognomonic since small arteries are involved in only 10% of cases and bile duct loss may not be extensive. In such cases the diagnosis of chronic rejection should only be made in the presence of progressive clinical deterioration.
27
Cardiac transplant atherosclerosis.
Billingham Me · PubMed · 1987 · 352 citations
INTERCELLULAR ADHESION MOLECULE 1 ON LIVER ALLOGRAFTS DURING REJECTION
David Adams, Jenny Shaw, Stefan G. Hübscher et al. · The Lancet · 1989 · 232 citations
HEPATIC TRANSPLANTATION IN EUROPE
H. Bismuth, Bo‐Göran Ericzon, Keith Rolles et al. · The Lancet · 1987 · 222 citations